The Expansion of Medical Access
The landscape of medical cannabis in the UK is shifting as major high-street pharmacy chain Boots announces the launch of its own medical cannabis service. While this represents a significant step toward mainstreaming patient access, it has prompted a debate regarding the necessity of rigorous clinical oversight.
Balancing Access and Safety
Critics of rapid market expansion, including recent commentary in The Times, argue that the promise of "strong clinical safeguards" must be matched by tangible, enforceable protections. For the medical cannabis community, the central challenge remains balancing the urgent need for patient access with the imperative to prevent inappropriate prescribing.
Reform advocates maintain that while caution is necessary, the focus should remain on expanding a regulated, evidence-based market that prioritises patient outcomes. By integrating cannabis into standard pharmacy pathways, the industry moves closer to destigmatising the treatment, provided that clinical governance remains the cornerstone of these new services.
Source: The Times




